Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.
It’s Official: UBS Confirms Deal To Buy Troubled Peer Credit Suisse For $3.2B In Swiss Central Bank-Brokered Deal
Swiss investment bank UBS Group AG (NYSE: UBS) and its beleaguered peer Credit Suisse AG (NYSE: